Delivery Order SPE2DB22D9353-SPE2DB25FX2EV
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,019.25 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a purchase under DLA's larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing the woman-owned small business...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg Systems, a type of intrauterine contraceptive device, with a period of performance through January 10, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
- The Defense Logistics Agency awarded a delivery order valued at $5,207.70 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems on September 24, 2025, with completion targeted for October 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price delivery order contract with no set-aside designation. The award represents a discrete delivery order issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a direct purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA. This delivery order carries no set-aside designation, allowing the woman-owned small business to compete on a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of June 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $20,720.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 15, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2EVDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $26,038.50 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for ultimate completion on October 8, 2025, with performance taking place at the contractor's Park Ridge facility. Mirena is a hormonal intrauterine device used for contraception and menstrual management, representing part of DMS Pharmaceutical Group's broader portfolio of pharmaceutical and medical supply products distributed to federal healthcare systems. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026. The IDC authorizes the DLA to issue firm fixed-price delivery orders for an extensive range of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in DLA procurement markets while providing direct distribution of pharmacy products to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.0k | 9/17/25 |